Literature DB >> 8748464

Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.

H Fukuzako1, K Takeuchi, Y Hokazono, T Fukuzako, K Yamada, T Hashiguchi, Y Obo, K Ueyama, M Takigawa, T Fujimoto.   

Abstract

Proton magnetic resonance spectroscopy (MRS) was performed in 30 medicated schizophrenic patients and 30 normal subjects. Two groups, each containing 15 schizophrenic patients and 15 age-and sex-matched normal subjects, received MRS examinations for different volumes of interest, either the frontal lobe or the medial temporal lobe. Schizophrenic patients showed a decrease in the ratios of N-acetylaspartate (NAA)/choline-containing compounds (Cho) and NAA/creatine-phosphocreatine (Cr). The patients also showed an increase in the ratio of Cho/Cr in the left medial temporal lobe but not in the left frontal lobe. The age at onset of illness correlated positively with the ratios of NAA/Cho and NAA/Cr in the medial temporal lobe. No significant correlation was observed between the ratios of NAA/Cho, NAA/Cr, or Cho/Cr in the left medial temporal and frontal lobes and clinical symptomatology as assessed by the Scale for the Assessment of Negative Symptoms and the Positive and Negative Syndrome Scale.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8748464     DOI: 10.1016/0925-4927(95)02622-5

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

Review 1.  Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Authors:  Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti
Journal:  Psychiatry Res       Date:  2012-09-13       Impact factor: 3.222

Review 2.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

Review 3.  [Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations].

Authors:  T Wobrock; H Scherk; P Falkai
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

Review 4.  1H MR spectroscopy in patients with mesial temporal epilepsy.

Authors:  M Hájek; M Dezortová; V Komárek
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

Review 5.  T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.

Authors:  Bethany K Bracken; Elizabeth D Rouse; Perry F Renshaw; David P Olson
Journal:  Psychiatry Res       Date:  2013-06-12       Impact factor: 3.222

6.  Neural models of schizophrenia.

Authors:  S Heckers
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

7.  Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls.

Authors:  Cheuk Y Tang; Joseph Friedman; Dikoma Shungu; Linda Chang; Thomas Ernst; Daniel Stewart; Arash Hajianpour; David Carpenter; Johnny Ng; Xiangling Mao; Patrick R Hof; Monte S Buchsbaum; Kenneth Davis; Jack M Gorman
Journal:  BMC Psychiatry       Date:  2007-06-19       Impact factor: 3.630

8.  Metabolite differences in the medial prefrontal cortex in schizophrenia patients with and without persistent auditory verbal hallucinations: a 1H MRS study.

Authors:  Qianjin Wang; Honghong Ren; Chunwang Li; Zongchang Li; Jinguang Li; Hong Li; Lulin Dai; Min Dong; Jun Zhou; Jingqi He; Joseph O'Neill; Yanhui Liao; Ying He; Tieqiao Liu; Xiaogang Chen; Jinsong Tang
Journal:  Transl Psychiatry       Date:  2022-03-23       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.